Loading company…
Xi'an Fusheng Biotechnology develops human blood substitutes and artificial blood products.
Xi'an Fusheng Biotechnology develops artificial blood products intended to replicate human red blood cells. Founded in 2023, the company is based in Xi'an, China, and operates research subsidiary Blood Oxygen Biotechnology Co., Ltd. In January 2026, it raised venture funding from Coastal Industry Investment.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign inWork at Xi'an Fusheng Biotechnology Co., Ltd.? This is my company